Annual Drug Patent Expirations for AUVELITY
Auvelity is a drug marketed by Axsome and is included in one NDA. There are ninety-three patents protecting this drug.
This drug has one hundred and twenty-two patent family members in thirty countries.
The generic ingredient in AUVELITY is bupropion hydrochloride; dextromethorphan hydrobromide. Additional details are available on the bupropion hydrochloride; dextromethorphan hydrobromide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
